Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Staging errors in prostatic cancer.

P Ray, C Feinstein, V Ray

    The Journal of Urology
    |December 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Public Health Approaches to Promote Health Equity for Individuals with Intellectual and Developmental Disabilities: A Systematic Review.

    Annals of public health & epidemiology·2026
    Same author

    Anxiety, depression and distress in family members of people who have experienced a critical care admission: a systematic review and Bayesian meta-analysis.

    Journal of intensive care·2025
    Same author

    Association between inflammation and post-intensive care syndrome: a systematic review.

    Anaesthesia·2024
    Same author

    Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants.

    Nature communications·2024
    Same author

    SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024
    Same author

    Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

    Physical review letters·2024
    Same journal

    On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

    The Journal of urology·2026
    Same journal

    Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

    The Journal of urology·2026
    Same journal

    Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

    The Journal of urology·2026
    Same journal

    The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

    The Journal of urology·2026
    Same journal

    Let's Shift the Focus from Death to Life after Fournier's Gangrene.

    The Journal of urology·2026
    Same journal

    Endourology and Nephrolithiasis.

    The Journal of urology·2026
    See all related articles

    Prostate cancer staging accuracy is questionable in large studies using tumor registry data. Our study found a significant 30% understaging error in registry data compared to surgical staging.

    Area of Science:

    • Oncology
    • Epidemiology
    • Medical Informatics

    Background:

    • Large-scale epidemiological studies of prostate cancer often rely on hospital tumor registry data for staging.
    • Concerns exist regarding the accuracy of this registry-based staging compared to clinical assessments.

    Purpose of the Study:

    • To evaluate the accuracy of tumor registry staging for prostate cancer.
    • To compare registry staging with surgical staging in a cohort of patients.

    Main Methods:

    • Retrospective analysis of 100 consecutive prostate cancer patients.
    • Comparison of staging information from the institutional tumor registry against post-surgical pathological staging.

    Main Results:

    • Tumor registry data exhibited a 30% understaging error rate when compared to surgical staging.

    Related Experiment Videos

  • This indicates a systematic inaccuracy in the registry data.

    • Conclusions:

    • Hospital tumor registry data may lead to significant understaging of prostate cancer.
    • This potential inaccuracy could impact large epidemiological studies and warrants further investigation across institutions.